Citryll

Oss, The Netherlands

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

$89.7M raised

Dec 2024

Series B

Biopharma Biotechnology Medical Medical Device Neuroscience

Top Investors

Seventure PartnersBioGeneration VenturesForbion Capital PartnersNovartis Venture FundJohnson & Johnson Innovation JJDC

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Citryll

How much funding has Citryll raised?

Citryll has raised $89.7M in total funding. The most recent round was Series B. The last funding was announced in December 2024.

Who are Citryll's investors?

Citryll's investors include Seventure Partners, BioGeneration Ventures, Forbion Capital Partners, Novartis Venture Fund, Johnson & Johnson Innovation JJDC.

Where is Citryll headquartered?

Citryll is headquartered in Oss, The Netherlands.

What does Citryll do?

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

What stage is Citryll at?

Citryll is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 9, 2024.

MLA

"Citryll — Funding & Investors." VCBacked, December 9, 2024, https://www.vcbacked.co/company/citryll. Accessed June 6, 2026.

APA

VCBacked. (2024). Citryll — Funding & Investors. Retrieved June 6, 2026, from https://www.vcbacked.co/company/citryll

Wikipedia (cite web)

{{cite web |title=Citryll — Funding & Investors |url=https://www.vcbacked.co/company/citryll |website=VCBacked |access-date=June 6, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 9, 2024.

Similar Companies in Biopharma